Enrofloxacin
Who holds supplier records for Enrofloxacin? 5 organisations hold a current record for Enrofloxacin: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3) and India (2).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Enrofloxacin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/enrofloxacin
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
3 of the 5 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Enrofloxacin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20625 · latest filing Jun 2007
- TURTLE PHARMA PRIVATE LTDIndiaActive DMF 33249 · latest filing Oct 2018
- Shaoxing Jingxin Pharmaceutical Co., Ltd.ChinaCEP
- Zhejiang Langhua Pharmaceutical Co. Ltd.ChinaCEP
- ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Enrofloxacin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2023-424 - Rev 02 Enrofloxacin for veterinary use, Process II | Sept 2025 | — |
| SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu | CN | CEP 2023-156 - Rev 01 Enrofloxacin for veterinary use | Jul 2025 | — |
| ZHEJIANG LANGHUA PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2012-034 - Rev 03 Enrofloxacin for veterinary use | Oct 2024 | — |
| ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shangyu | CN | R1-CEP 2013-086 - Rev 01 Enrofloxacin for veterinary use | Jan 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Enrofloxacin are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 24857 · filed Apr 2011
Overview
Enrofloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL15511).
Chemical identity
- IUPAC name
- 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
- Canonical SMILES
- CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
- InChIKey
- SPFYMRJSYKOXGV-UHFFFAOYSA-N
- Synonyms
- Baytril, BAY VP 2674, Enrofloxacin, Enrofloxacine, Enrofloxacin for veterinary use, Enrofloxacino, NSC-758616, Enrofloxacinum, endrofloxicin, Bay-Vp-2674, CHEBI:35720, Enrofloxacin base
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Enrofloxacin?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Enrofloxacin: MATRIX PHARMACORP PRIVATE LTD (India), TURTLE PHARMA PRIVATE LTD (India), Shaoxing Jingxin Pharmaceutical Co., Ltd. (China), Zhejiang Langhua Pharmaceutical Co. Ltd. (China) and ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Enrofloxacin Drug Master Files are active?
MATRIX PHARMACORP PRIVATE LTD (DMF 20625) and TURTLE PHARMA PRIVATE LTD (DMF 33249). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Enrofloxacin records mean?
1 organisation has only inactive Type II DMFs for Enrofloxacin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Enrofloxacin have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Enrofloxacin on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu (CN), ZHEJIANG LANGHUA PHARMACEUTICAL CO., LTD. Linhai (CN) and ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shangyu (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Enrofloxacin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Enrofloxacin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.